Prednisone Recruiting Phase 3 Trials for Systemic Lupus Erythematosus (SLE) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02558517Evaluation of the Discontinuation of Maintenance Corticosteroid Treatment in Quiescent Systemic Lupus